EGFL7, which is associated with the ECM, is linked to primary tumor growth, angiogenesis, tumor metastasis, and drug resistance, highlighting the multifaceted role of angiocrine factors in cancer progression 279. The gene discussed is EGFL7; the disease is neoplasm.